. Author manuscript; available in PMC: 2012 Oct 1.

Published in final edited form as: J Nucl Med. 2011 Sep 8;52(10):1541–1549. doi: 10.2967/jnumed.111.091439

TABLE 2.

Lesion Characteristics

Characteristic	n	Mean ± SD	Median	Range
Tumor site
Soft tissue or lymph node	113 (22)
Lung	14 (3)
Axial skeleton or spine	225 (45)
Long bone or pelvis	153 (30)

PET measures (LBM-adjusted)
¹⁸F-fluoroestradiol mean SUV_LBM		1.9 ± 1.5	1.5	0.0–10.2
¹⁸F-fluoroestradiol maximum SUV_LBM		2.9 ± 1.9	2.3	0.2–13.0
¹⁸F-FDG maximum SUV_LBM (n = 492)		3.2 ± 2.2	2.5	0.8–16.5
¹⁸F-fluoroestradiol maximum/¹⁸F-FDG maximum ratio (n = 492)		1.1 ± 0.9	0.9	0.1–5.6

PET measures (total mass-adjusted)
¹⁸F-fluoroestradiol mean SUV		3.0 ± 2.4	2.3	0.0–14.7
¹⁸F-fluoroestradiol maximum SUV		4.5 ± 3.1	3.6	0.3–18.7
¹⁸F-FDG maximum SUV (n = 492)		5.0 ± 3.4	3.8	1.2–25.0

n = 505 lesions in 91 patients. Data in parentheses are percentages.